COX6A1
protein-codingcytochrome c oxidase subunit 6A1, the group of Mitochondrial complex IV: cytochrome c oxidase subunits
Gene summary
Cytochrome c oxidase (COX), the terminal enzyme of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. It is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in the electron transfer and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes polypeptide 1 (liver isoform) of subunit VIa, and polypeptide 1 is found in all non-muscle tissues. Polypeptide 2 (heart/muscle isoform) of subunit VIa is encoded by a different gene, and is present only in striated muscles. These two polypeptides share 66% amino acid sequence identity. It has been reported that there may be several pseudogenes on chromosomes 1, 6, 7q21, 7q31-32 and 12. However, only one pseudogene (COX6A1P) on chromosome 1p31.1 has been documented. [provided by RefSeq, Jul 2008]
- COX6A
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014467
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014467
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *COX6A1* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of March 18, 2024. The *COX6A1* gene encodes an isoform of a subunit of cytochrome *c* oxidase (COX). *COX6A1* was first reported in relation to autosomal recessive primary mitochondrial disease in 2014 (PMID: 25152455), in two Japanese probands with early childhood onset peripheral neuropathy. A third case with similar clinical features was reported in 2016 (PMID: 26302975). While various names have been given to the constellation of features seen in those with *COX6A1*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *COX6A1* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included one homozygous five base pair intronic deletion resulting in aberrant splicing and loss of function in all reported cases. The mechanism of disease is loss of function. This gene-disease association is also supported by the known biochemical function of COX6A1 as a subunit of complex IV, functional alteration in non-patient cells (PMID: 20307258), and a mouse model that recapitulates the clinical and biochemical phenotype seen in affected individuals (PMID: 25152455) In summary, there is strong evidence to support the relationship between *COX6A1* and autosomal recessive primary mitochondrial disease. While the three publications related to this gene-disease curation covered a span of six years (2010-2016), this Expert Panel elected to classify this association as strong given that a single variant only has been reported in the three unrelated probands, and two of these probands were from consanguineous families, raising the possibility other genetic etiologies could be present. We will re-evaluate this gene-disease relationship in the future to determine if an upgraded classification of Definitive is warranted. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on March 18, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0014467
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COX6A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004373.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 34 | 34 | ||||
| missense | 50 | 3 | 53 | |||
| nonsense | 1 | 1 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 57 | 37 | 0 | 94 |
Highest pathogenic variant AF is 0.000042320033
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004364.2 | 3 | MANE Select | |
| Ensembl | ENSP00000229379.2 | 3 | MANE Select | |
| Ensembl | ENSP00000602251.1 | 3 | Standard | |
| Ensembl | ENSP00000602251.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cardiac muscle contraction - Homo sapiens (human)
- Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
- Alzheimer,s disease - Homo sapiens (human)
- Huntington,s disease - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
Biological Process
- generation of precursor metabolites and energy
- mitochondrial electron transport, cytochrome c to oxygen
- aerobic respiration
- regulation of catalytic activity
- proton transmembrane transport
Molecular Function
- cytochrome-c oxidase activity
- enzyme regulator activity
Cellular Component
- mitochondrion
- mitochondrial inner membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000229379
- Coding exons
- 3
- Length
- 2653
- Individuals with no LoFs
- 125725
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 22
- Defined
- 125747
- p
- 0.0000875
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.42 | 99 | 66.5 | 1.49 | 0.00000312 | 696 |
| Missense (PolyPhen) | 22 | 16.847 | 1.3059 | 220 | ||
| Synonymous | -1.93 | 41 | 28.0 | 1.46 | 0.00000139 | 233 |
| Loss of Function | 0.247 | 4 | 4.57 | 0.875 | 1.96e-7 | 48 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000055 | 0.000054 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00014 | 0.00014 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease, recessive, intermediate type, D (CMTRID) [MIM:616039]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Recessive intermediate forms of Charcot-Marie-Tooth disease are characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. {ECO:0000269|PubMed:25152455}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0899
Intolerance Scores
- LoFtool
- 0.356
- RVIS EVS
- -0.32
- RVIS percentile EVS
- 31.46
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.575
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |